QuailCRO's Investigative Sites capabilities

 

Medical Devices trials - dentistry, cardiology, orthopaedy and internal medicine
Gastroenterology
Higher rates of cirrhosis (with associated diseases)
    Hepatitis B & C, Irritable Bowel Syndrome and Ulcerative Colitis, Esophagitis, gastric ulcer and acute diarrhoea
Urology/Oncology - complete medical history file for each patient
Benign Prostatic Hypertrophy, Prostate and bladder cancer
Cardiology - first cause of morbidity and mortality in CEE
CHF, AMI, HTA, Instable angina, Atherosclerosis, arrhytmia
Rheumatology - Rheumatoid Poliarthritis
Nephrology
Chronic Renal Disease and Hemodialysis
Metabolic diseases & Diabetes - new patients diagnosticated each year
Diabetes Mellitus type I and type II, Hypercolesterolemia, Dislipidemia and Obesity
Dermatology - hundreds of state and private clinics
Atopic dermatitis, psoriasis, skin inflamation
Infectious diseases
Orthopedy
Central Nervous System
Multiple Sclerosis, Diabetic and periferal neuropathy
Proven access to a specific population of hyponatraemic patients with CHF, cirrhosis and electrolites disorders

County hospitals and Emergency hospitals with large patients' databases,covering a population of 85 millions inhabitants.

The basic training for all QuailCRO investigators includes 6 years of medical school education in an university ( MD degree ) followed by 5 years of residency and at least 5 years for senior specialist degree.
They are also trained in various subspecialties related to their primary grade and in ICH/GCP guidelines.

Due to our past and present experience in clinical trials and pharmaceutical market, we are in close and permanent contact with academic opinion leaders from all over the region. This is not limited to the therapeutic areas shown above only.

QuailCRO team builds strong and long-term relationship with the investigators and coordinators.